Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Compare
ISA Comparison Table
Podcasts
Video
Events
Awards
- Advertisment -
Tags
AstraZeneca
Tag:
AstraZeneca
Shares
FTSE 100 rallies with global equities as investors look past US recession
Natasha Doris
-
29/07/2022
0
Shares
AstraZeneca revenue grows to $22.2bn, raises FY guidance on Covid-19 treatments
Natasha Doris
-
29/07/2022
0
News
Oxford BioMedica agrees 3-year extension to AstraZeneca Covid-19 vaccine deal
Natasha Doris
-
01/07/2022
0
News
AstraZeneca receives recommendations for EU approvals for two breast cancer treatments
Natasha Doris
-
27/06/2022
0
Shares
AstraZeneca revenues increase 60%, Covid-19 treatments decline
Natasha Doris
-
29/04/2022
0
News
AstraZeneca treatment Ultomiris approved in US
Natasha Doris
-
28/04/2022
0
News
AstraZeneca treatment Tremelimumab accepted for US priority review
Natasha Doris
-
25/04/2022
0
Shares
FTSE 100 dragged by weaker miners
Anshula Kumar
-
21/04/2022
0
Shares
AstraZeneca receives boost from Covid vaccine
Liam Roche
-
29/07/2021
0
Shares
AstraZeneca gets all-clear for £27.5bn Alexion acquisition
Liam Roche
-
14/07/2021
0
1
2
3
4
Page 1 of 4
Most Read
Here’s why Vistry shares have fallen too far
22/11/2024
Share Tip: Ferro-Alloy Resources – Smithers marketing study opens up massive potential for this £25m company, with its shares exploding 130% – More to...
22/11/2024
AIM movers: Reassuring trading by Shield Therapeutics and ex-dividends
21/11/2024
FTSE 100: JD Sports sinks as investors digest Nvidia earnings
21/11/2024
